Université Paris 13, 74 rue Marcel Cachin, Bobigny, France.
Leeds Centre for Respiratory Medicine, St James's University Hospital, Leeds, UK.
BMC Fam Pract. 2019 Dec 20;20(1):178. doi: 10.1186/s12875-019-1068-7.
Many studies have investigated the ways in which physicians decide whether to prescribe antibiotics, but very few studies have focused on the reasons for which general practitioners (GPs) choose to prescribe a particular antibiotic in a specific clinical situation. Improvements in our understanding of the rationale behind GPs' decisions would provide insight into the reasons for which GPs do not always prescribe the antibiotic recommended in clinical practice guidelines and facilitate the development of appropriate interventions to improve antibiotic prescription. The objective of the study was to understand the rationale used by GPs to decide which antibiotic to prescribe in a specific clinical situation, and to propose a model representing this rationale.
We used a three-step process. First, data were collected from interviews with 20 GPs, and analysed according to the grounded theory approach. Second, data were collected from publications exploring the factors used by GPs to choose an antibiotic. Third, data were used to develop a comprehensive model of the rationale used by GPs to decide which antibiotic to prescribe.
The GPs considered various factors when choosing antibiotics: factors relating to microbiology (bacterial resistance), pharmacology (adverse effects, efficacy, practicality of the administration protocol, antibiotic class, drug cost), clinical conditions (patient profile and comorbid conditions, symptoms, progression of infection, history of antibiotic treatment, preference), and personal factors (GP's experience, knowledge, emotion, preference).
Various interventions, targeting all the factors underlying antibiotic choice, are required to improve antibiotic prescription. GP-related factors could be improved through interventions aiming to improve the GPs' knowledge of antibiotics (e.g. continuing medical education). Factors relating to microbiology, pharmacology and clinical conditions could be targeted through the use of clinical decision support systems in everyday clinical practice.
许多研究都探讨了医生决定是否开具抗生素的方式,但很少有研究关注全科医生(GP)在特定临床情况下选择特定抗生素的原因。深入了解 GP 决策背后的原理,可以帮助我们理解 GP 为何并非总是遵循临床实践指南中推荐的抗生素,从而为制定适当的干预措施以改善抗生素处方提供依据。本研究旨在了解 GP 在特定临床情况下决定开具哪种抗生素的原理,并提出代表这一原理的模型。
我们采用了三步法。首先,我们对 20 名全科医生进行访谈,收集数据,并根据扎根理论方法进行分析。其次,我们从探索 GP 选择抗生素时使用的因素的文献中收集数据。最后,我们使用这些数据开发了一个代表 GP 决定开具哪种抗生素的原理的综合模型。
GP 在选择抗生素时会考虑多种因素:与微生物学(细菌耐药性)、药理学(不良反应、疗效、给药方案的实用性、抗生素类别、药物成本)、临床情况(患者特征和合并症、症状、感染进展、抗生素治疗史、偏好)和个人因素(GP 的经验、知识、情感、偏好)相关的因素。
需要针对抗生素选择背后的所有因素实施各种干预措施,以改善抗生素处方。可以通过继续医学教育等干预措施提高 GP 对抗生素的了解来改善与 GP 相关的因素。可以通过在日常临床实践中使用临床决策支持系统来针对微生物学、药理学和临床情况相关因素进行干预。